Merck’s Winrevair Well Positioned To Benefit From Medicare Part D Redesign

 
• By Cathy Kelly
  
Merck's PAH Drug Is Priced Well Above ICER-Recommended Range • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Market Access

More from Pink Sheet